Abstract PD1-07: A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer heavily pre-treated with HER2-targeted therapy

Authors: Adam Brufsky, Malik Zulfiqar, Julio Peguero, Kate Lathrop, Gajanan Bhat, Francois Lebel

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-pd1-07

Source: Full article